Clinical trial
A Phase II Trial of Oligo-Fucoidan in Radiation Induced Ling Injury
NCT05616507 is registered in ClinicalTrials.gov with Taipei Medical University WanFang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Trial of Oligo-Fucoidan in Radiation Induced Ling Injury
- Lead sponsor
- Taipei Medical University WanFang Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 30, 2022
- Completion date
- December 30, 2025
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
radiation toxicity